Desperate Shorter Attackers Create Star Scientific Buying Opportunity
This is just a short note in response to a number of reader inquiries regarding the most recent attempt by short attackers to knock down the Star Scientific stock price. First, however, I should clarify that I'm really not that concerned about short-term stock prices, especially in regard to Star Scientific. The potential of anatabine citrate, the active ingredient in Anatabloc, has been validated by the completed thyroiditis study performed by a number of noted endocrinologists from Johns Hopkins Medical School, chiefly the director of endocrinology and metabolism, Dr. Paul W. Ladenson.
You Must Be A Subscriber To View This Content.
If you are already a subscriber, click the login button below to get access. Not yet a subscriber? Checkout our publication below and get access today!
Breakthrough Technology Alert
This is the best time to be investing in world-changing technologies, as unprecedented innovations are taking off right now… Breakthrough Technology Alert tirelessly researches these exciting new breakthrough technologies to keep you well informed, outline specific opportunities, and keep you ahead of the game.